7.71
Schlusskurs vom Vortag:
$8.25
Offen:
$8.28
24-Stunden-Volumen:
11,897
Relative Volume:
0.15
Marktkapitalisierung:
$43.40M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.3175
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
-20.98%
1M Leistung:
-23.34%
6M Leistung:
+37.86%
1J Leistung:
-19.16%
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Firmenname
Aligos Therapeutics Inc
Sektor
Branche
Telefon
(800) 466-6059
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie ALGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ALGS
Aligos Therapeutics Inc
|
8.11 | 57.35M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
633.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.50 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.98 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.29 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-09 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
How to build a dashboard for Aligos Therapeutics Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Why Aligos Therapeutics Inc. stock remains on buy listsJuly 2025 Patterns & Weekly Top Stock Performers List - newser.com
How buybacks impact Aligos Therapeutics Inc. stock valueMarket Growth Report & Weekly High Potential Stock Alerts - newser.com
How to forecast Aligos Therapeutics Inc. trends using time series2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com
Is Aligos Therapeutics Inc a good long term investmentChart Pattern Recognition & Free Rapid Return Acceleration - earlytimes.in
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosTrade Entry Report & AI Enhanced Market Trend Forecasts - newser.com
Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Multi factor analysis applied to Aligos Therapeutics Inc.Trade Analysis Report & Real-Time Volume Surge Alerts - newser.com
Aligos Therapeutics, Inc. (ALGS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is Aligos Therapeutics Inc. stock supported by strong fundamentalsEarnings Overview Report & Precise Buy Zone Tips - newser.com
Published on: 2025-10-31 04:14:04 - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosDollar Strength & Weekly Stock Performance Updates - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock safe for risk averse investors2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com
Can Aligos Therapeutics Inc. (5WK0) stock double in coming yearsTrade Entry Report & Safe Capital Growth Plans - newser.com
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Aligos Therapeutics (Nasdaq: ALGS) to announce financial results Nov 6, 2025 - Stock Titan
Aligos Therapeutics (ALGS) Expected to Announce Earnings on Wednesday - MarketBeat
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):